PBMC from DRB1*07:01 (DR7)+ subjects were stained with DR7-matched spike and nucleocapsid tetramers, magnetically enriched, and analyzed by flow cytometry. (A-C) Representative flow cytometry plots of live CD14–CD20–CD3+CD8–CD4+ gated events with indicated tetramer+ gates for the 4 epitope-specific populations from a pre-pandemic negative control (A), a non-hospitalized subject (B), and a previously hospitalized subject (C). (D) Representative flow cytometry plots of combinatorial tetramer staining of live CD14–CD20–CD3+CD8–CD4+ gated events (left column) and live CD14–CD20–CD3+CD8+CD4– gated events (right column). (E) Summary of individual epitope-specific CD4+ T cell frequencies and combined tetramer+ cells per million CD4+ T cells. Uninfected n = 9, non-hospitalized n = 31, previously hospitalized n = 9. Statistics by Kruskal-Wallis and Dunn’s multiple comparisons tests. (F-H) Correlations between DR7:S310+ and DR7:S166+ (spike-specific) cell frequencies (F), between DR7:N305+ and DR7:N329+ (nucleocapsid-specific) cell frequencies (G), and between nucleocapsid-specific (combined DR7:N305+ and DR7:N329+) and spike-specific (combined DR7:S310+ and DR7:S166+) cell frequencies (H), with r and significance from Spearman correlation. (I) Comparison of timing of first time point sample collection of all non-hospitalized and previously hospitalized subjects in the MassCPR cohort. (J) Summary of circulating anti-S, anti-RBD, and anti-N IgG antibody levels from paired plasma samples. AU denotes arbitrary units. Statistics by Mann-Whitney tests. Solid horizontal lines indicate median values. Dotted horizontal line indicates limit of detection. *p < 0.05, **p < 0.01, ***p < 0.001. ns = not statistically significant.